Injection site reactions to TNF-α blocking agents with positive skin tests

被引：46

作者：

Benucci, M. ^{[1
]}

Manfredi, M. ^{[1
]}

Demoly, P. ^{[1
]}

Campi, P. ^{[1
]}

机构：

[1] Nuovo Osped S Giovanni di Dio, Rheumatol Unit ASL 10, I-50143 Florence, Italy

来源：

ALLERGY | 2008年 / 63卷 / 01期

关键词：

adalimumab; drug eruptions; etanercept; skin tests; tumor necrosis factor-alpha antagonists;

D O I：

10.1111/j.1398-9995.2007.01536.x

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

[No abstract available]

引用

页码：138 / 139

页数：3

共 6 条

[1] Prevention and treatment of hymenoptera venom allergy:: guidelines for clinical practice [J].

Bonifazi, F ;

Jutel, M ;

Biló, BM ;

Birnbaum, J ;

Muller, U .

ALLERGY, 2005, 60 (12) :1459-1470

[2]

Dore RK, 2007, CLIN EXP RHEUMATOL, V25, P40

[3]

Pichler Werner J., 2007, P168, DOI 10.1159/000104199

[4] Adalimumab, a fully human anti-tumor necrosis factor a monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate - The ARMADA trial [J].

Weinblatt, ME ;

Keystone, EC ;

Furst, DE ;

Moreland, LW ;

Weisman, MH ;

Birbara, CA ;

Teoh, LA ;

Fischkoff, SA ;

Chartash, EK .

ARTHRITIS AND RHEUMATISM, 2003, 48 (01) :35-45

[5] Eosinophilic cellulitislike reaction to subcutaneous etanercept injection [J].

Winfield, H ;

Lain, E ;

Horn, T ;

Hoskyn, J .

ARCHIVES OF DERMATOLOGY, 2006, 142 (02) :218-220

[6]

Zeltser R, 2001, ARCH DERMATOL, V137, P893

← 1 →